The Managing the deadly duo of COPD and cardiovascular risk clinical audit
has been endorsed by The Royal New Zealand College of General
Practitioners (RNZCP) and approved for up to 13 CME credits for Continuing
Professional Development (CPD) purposes. Credits will be uploaded on behalf
of RNZCGP Fellows.
Activity aim
In this clinical audit, you will identify patients with COPD who are experiencing exacerbations causing elevated cardiovascular risk. In a consultation setting with the patient, you will step through a series of online structured questions and guidelines recommendations to evaluate current management, including non-pharmacological care, self-management support and pharmacological therapies. If appropriate, you will have an opportunity to implement changes with your patient to improve clinical outcomes.
Why take part in this program?
- Access a comprehensive pre-learning activity presented by A/Prof Amy Chan, Professor Jeff Harrison, Conjoint A/Prof Chee Khoo, Conjoint and A/Prof Belinda Cochrane.
- Identify five suitable patients for this activity who have previously been diagnosed with chronic obstructive pulmonary disease, who are experiencing exacerbations causing elevated cardiovascular risk
- Earn 13 CME credits upon completion
- All participants will receive a certificate at the completion of the audit which can be downloaded for CPD purposes
Inclusion criteria
Patients who are eligible for this clinical audit are adults who are:
- aged 18 years or older
- previously diagnosed with COPD
- 1 or more severe COPD exacerbations requiring hospitalisation in past 12 months, OR 2 or more moderate exacerbations in the past 12 months
How long should it take?
The program has been designed to take approximately 4-6 weeks to complete. This includes patient recall from your practice, patient consult and program evaluation.
Tips to recruit patients
Recruitment may occur:
- Opportunistically as you consult appropriate patients as part of usual care
- By active recall
Click the 'proceed' button to commence this course.
Learning outcomes
Presenters
A/Prof Amy Chan is the Head of School of Pharmacy at the University of Auckland, and Respiratory Lead of the Medicines Intelligence Group. A clinical pharmacist with over 20 years of expereince, she now leads a research team exploring digital technology, big data, and respiratory health, with a focuse on using data to improve care delivery. She is Clinical Director for Asthma NZ and on the steering group for New Zealand's respiratory health strategy BREATHE.
Professor Harrison is a hospital pharmacist by training, latterly specialising in cardiovascular and intensive care medicine. As an academic he has a particular focus on the optimal use of medicines, clinical decision support and comparative effectiveness studies.
My research benefits from a strong background in clinical research and clinical pharmacology. I have extensive experience in the application of clinical epidemiology, health technology assessment and evidence-based medicine. I have practical experience of clinical trial design, meta-analysis, basic biostatistics and pharmacoeconomic analysis.
After gaining a BSc(Hons) in Pharmacy and completing my clinical training in England I took a year out to travel the world followed by a PhD in Orthopaedic Surgery at the University of Bristol undertaking two clinical trials comparing the effectiveness of pharmacological and mechanical approaches to venous thromboprophylaxis in patients undergoing joint replacement surgery. After moving to New Zealand in 2001 I undertook further studies in Evidence-based Medicine at McMaster University, Canada, followed by becoming a Board Certified Pharmacotherapy Specialist in the US.
An educator with a special interest in chronic disease, Conjoint A/Prof Khoo has been a practicing solo GP in Ingleburn, NSW Australia since 1990. He is the Chair of the Education Working Group at the Diabetes, Obesity and Metabolism Translational Research Unit (DOMTRU). He is a member of the RACGP’s Specific Interest Groups in Diabetes and Obesity Management and the Editor-in-chief at GPVoice.com.au
Conjoint A/Prof Belinda Cochrane is an SME reviewer for the COPD-X Guidelines Committee for cardiology related respiratory papers, and a member of the Statewide Respiratory Network in New South Wales. Her research interests include COPD and its relationship with cardiac disease, breathlessness and inhaler device capability.
Related content
